Explore our services

Legal Notice

Who we are

CREAPHARM GROUP SAS
Allée des Landais
51100 Reims
France
Phone number : +33 (0)3 26 79 00 00
Email : contact@creapharm.com

Capital : 317’000€
Identification number : SIREN 329096432
VAT number : FR28329096432

Website hosting

o2switch
222 Bd Gustave Flaubert
63000 Clermont-Ferrand
France
Phone number : +33 4 44 44 60 40

Entity responsible for the processing of personal data

CREAPHARM GROUP SAS
Email : contact@creapharm.com

 

What data is collected and what for ?

When you browse the site, certain user information may be collected actively (surname, first name, postal address, telephone, email address) or passively (that you have not actively provided) such as browser used, the domain name, the pages visited and the duration of the visit, using various tools and means, including cookies, Internet markers and the collection of navigation data, for the sole purpose of improve the site.

No information collected is disclosed to third parties for advertising or other purposes except that it may be transmitted to CREAPHARM GROUP entrepreneurs who collaborate in the programming or provide technical support for the hosting and operation of the site. Communications made through the site may not be confidential and may therefore be read or intercepted by others.

CREAPHARM GROUP is responsible for processing the data collected on the Site. The user is informed in particular that, in accordance with article 32 of the amended Data Protection Act of 6 January 1978 (article 32 de la loi Informatique et libertés du 6 janvier 1978 modifiée), the information he communicates on the Site is necessary to respond to his request and is intended for the services in charge of respond to their request for the purpose of following up on this request.

In accordance with the provisions of articles 39 and 40 of the law “Informatique et Libertés” of January 6, 1978 (articles 39 et 40 de la loi « Informatique et Libertés » du 6 janvier 1978 modifiée) as amended, the user has the right to access, rectify, update and delete information concerning him. This right can be exercised by contacting info@creapharm.com, specifying in the subject of the mail “Personal data” and attaching a copy of his proof of identity.

This CREAPHARM GROUP website uses Google Analytics, a web analytics service provided by Google, Inc. (“Google”) to help CREAPHARM GROUP analyze how visitors use the site. The information generated by the cookie about your use of the website (including your IP address) will be transmitted to and stored by Google on servers in the United States.

User’s consent

You may refuse the use of cookies by selecting the appropriate settings on your browser or on the consent banner situated at the bottom right hand of your screen. However please note that if you do this you may not be able to use the full functionality of this website.

By using this website, you consent to the processing of data about you by Google in the manner and for the purposes set out above.

Our use of collected data

The data collected is solely use to analyze how visitors navigate and use our website.

Duration of retention of personal data

Collected data is kept available during 24 months.

Use of cookies

For more information about our use of cookies, please visit our Cookie policy page.

The cookie or connection witness is a block of data which is used to record information relating to the navigation of users on the Site. This Site uses cookies that help us enhance your experience when you browse our Site and also allow us to improve it. A cookie is a small file of letters and numbers that we store on your browser or your computer’s hard drive, if you agree. Cookies contain information that is transferred to your computer’s hard drive. We only use analytical/performance cookies. These cookies allow us to recognize and count the number of visitors to our Site and to see how visitors use our Site. These cookies help us improve the way our Website works. Please note that third parties may also use analytical/performance cookies, over which we have no control. If you do not want us to use cookies as we have described above, or if you change your mind after consenting to our use of cookies, you can delete and block cookies on this Site through your browser or via the specific unsubscribe module. If you use your browser settings to block all cookies, some parts of our Website may not work.

Disclaimer

CREAPHARM GROUP strives to keep the site www.creapharm.com up to date, however CREAPHARM GROUP cannot guarantee at all times the completeness and accuracy of the information published there, nor can it be held responsible for the consequences of their use by Internet users. This Site may contain links to other Internet sites, however CREAPHARM GROUP cannot be held responsible for any damage arising from the use of goods or services made available on these sites or information published on them. CREAPHARM GROUP cannot be held responsible for technical problems such as service interruptions or computer malfunctions.

You also have the right to give instructions on the fate of your data after your death. In accordance with the provisions of article 38 of the law “Informatique et Libertés” of January 6, 1978 as amended (article 38 de la loi « Informatique et Libertés » du 6 janvier 1978 modifiée), the user may also object, for legitimate reasons, to the processing of his data and without reason and free of charge, for their data to be used for commercial prospecting purposes.

The information collected on this Site will be kept for the legal retention period.
The user of the Site is required to comply with the provisions of the amended Data Protection Act of 6 January 1978 (loi Informatique et libertés du 6 janvier 1978 modifiée), the violation of which is punishable by criminal penalties. In particular, he must refrain, with regard to the personal information to which he has access, from any collection, from any misuse, and in general, from any act likely to infringe the privacy or reputation of persons.

Intellectual and industrial property rights

The presentation and content of this Site together constitute a work protected by the laws in force on intellectual property, of which CREAPHARM GROUP or third parties having authorized the latter to use them, are the holders. Site Content means the general structure, texts, images, whether animated or not, and sounds of which the Site is composed. Any representation, reproduction, transcription, adaptation, translation, imitation, distribution, redistribution, partial or total, of this Site and its Content on any medium or by any process whatsoever is strictly prohibited without the prior express written authorization of CREAPHARM GROUP and would constitute an infringement punishable by articles L. 335-2 and following of the Intellectual Property Code (articles L. 335-2 et suivants du Code de la Propriété Intellectuelle). The names, logos, labels, packaging, bottles and slogans are, unless otherwise specified, protected by industrial and/or intellectual property rights held by CREAPHARM GROUP. Any reproduction, representation, use, adaptation, modification, incorporation, translation, partial or total of these elements without the express prior written consent of CREAPHARM GROUP constitutes an act of infringement. As such, protected against any imitation and/or reproduction under the terms of articles L. 713-2 and 3 of the Intellectual Property Code (articles L. 713-2 et 3 du Code de la Propriété Intellectuelle).

Gender equality index

CREAPHARM CLINICAL SUPPLIES

Index 76/100
Difference in gross annual remuneration: 36/40
Improvement objective: reduce the pay gap, particularly among managers
Difference in the rate of individual increases: 35/35
Percentage of female employees who received a raise within one year of returning from maternity leave: 0/15
Improvement objective: ensure that all employees returning from maternity leave benefit from a pay increase the year of their return
Number of employees of the under-represented gender in the top 10: 5/10
Improvement objective: promote access of men to the highest positions according to their representativeness within the company

CREAPHARM INDUSTRY

Index 99/100
Annual gross pay gap: 39/40
Difference in the rate of individual increases: 35/35
Percentage of female employees who received a raise within one year of returning from maternity leave: 15/15
Number of employees of the under-represented gender in the top 10: 10/10